The slip
PARKINSON RECEIPTno. 14747
30 Oct 2026, 02:50 UTCdopamine neurons, braak
predictionADAM8 in dopamine neurons tracks Braak Lewy-body stage
registered845268e2b29418e4
discovery-0.53 p=0.143 n=9
replication+0.11 p=0.777 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.53, p 0.143)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTd1cc41549cef51f01abf21d9…
follows 6e86d19e43a7…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 14747: ADAM8 in dopamine neurons, braak
- power
- full sample -0.23 (p 0.355, n 18), 95% CI -0.63 to +0.26. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.23 (p 0.365, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.32 (p 0.198, n 18). could be the mix.
- skeptic
- leave-one-out range -0.41 to -0.13, sign flips 0; without severely affected donors -0.23 (p 0.355, n 18). fragile.
- cell type
- strongest in microglia: -0.61 (p 0.0077, n 18) vs -0.23 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ADAM8 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ADAM8 · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.27 p 0.328 (needs p < 1.6e-4)